CLL-137 SEQUOIA: Results of a Phase 3 Randomized Study of Zanubrutinib Versus Bendamustine + Rituximab (BR) in Patients With Treatment-Naïve (TN) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/ SLL)
Resource Type
Article
Authors
Kahl, Brad S. ; Giannopoulos, Krzysztof ; Jurczak, Wojciech ; Šimkovič, Martin ; Shadman, Mazyar ; Österborg, Anders ; Laurenti, Luca ; Walker, Patricia ; Opat, Stephen ; Chan, Henry ; Ciepluch, Hanna ; Greil, Richard ; Tani, Monica ; Trnéný, Marek ; Brander, Danielle M. ; Flinn, Ian W. ; Grosicki, Sebastian ; Verner, Emma ; Brown, Jennifer R. ; Ghia, Paolo ; Li, Jianyong ; Tian, Tian ; Zhou, Lei ; Marimpietri, Carol ; Paik, Jason C. ; Cohen, Aileen ; Robak, Tadeusz ; Hillmen, Peter ; Tam, Constantine S.
Source
In Clinical Lymphoma, Myeloma and Leukemia October 2022 22 Supplement 2:S269-S270
Subject
Language
ISSN
2152-2650